Israel Englander Aptevo Therapeutics Inc. Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.17 - $0.38 $17,783 - $39,751
104,608 New
104,608 $18,000
Q1 2021

May 17, 2021
SELL
$27.86 - $40.59 $173,567 - $252,875
-6,230 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$6.21 - $48.36 $38,688 - $301,282
6,230 New
6,230 $228,000
Q3 2020

Nov 16, 2020
SELL
$7.21 - $9.37 $251,859 - $327,312
-34,932 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$3.11 - $9.27 $108,638 - $323,819
34,932 New
34,932 $292,000

About Aptevo Therapeutics Inc.

APVO Quotes by TradingView
  • Ticker APVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,090,640
  • Market Cap $22.4M
  • Description
  • Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...
More about APVO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email